NXTHERA
NxThera develops medical technologies to treat a variety of endourology conditions, including BPH. The company's technology platform utilizes a simple, minimally invasive, vapor therapy designed to measurably improve urinary flow and patient quality of life. BPH afflicts more than 32 million men in the United States.
NXTHERA
Social Links:
Industry:
Biotechnology Health Care Medical Medical Device
Founded:
2008-01-01
Address:
Maple Grove, Minnesota, United States
Country:
United States
Website Url:
http://www.nxthera.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
123.49 M USD
Technology used in webpage:
Comcast Cisco Ironport Cloud ATT DNS Tribulant Slideshow Gallery
Similar Organizations
Companion Medical
Companion Medical develops a technology designed for those living with Type 1 or Type 2 insulin-dependent diabetes.
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
American Medical Systems
American Medical Systems investment in Series D - NxThera
Boston Scientific
Boston Scientific investment in Series D - NxThera
Mitsui Global Investment
Mitsui Global Investment investment in Series D - NxThera
Perseverance Capital Management
Perseverance Capital Management investment in Series C - NxThera
American Medical Systems
American Medical Systems investment in Series B - NxThera
Arboretum Ventures
Arboretum Ventures investment in Series B - NxThera
Aberdare Ventures
Aberdare Ventures investment in Series B - NxThera
Bonsal Capital
Bonsal Capital investment in Series A - NxThera
Official Site Inspections
http://www.nxthera.com
- Host name: bsciweb-cf2.bsci.com
- IP address: 204.155.22.18
- Location: Minneapolis United States
- Latitude: 45.0936
- Longitude: -93.2407
- Metro Code: 613
- Timezone: America/Chicago
- Postal: 55432
More informations about "NxThera"
NxThera - Crunchbase Company Profile & Funding
NxThera develops medical technologies to treat a variety of endourology conditions, including BPH. The company's technology platform utilizes a simple, minimally invasive, vapor therapy …See details»
NxThera Company Profile 2024: Valuation, Investors, Acquisition
Developer of a medical based thermal therapy device designed to treat prostate cancer and other endourologic conditions.See details»
Boston Scientific Closes NxThera Acquisition - Apr 30, 2018
MARLBOROUGH, Mass., April 30, 2018 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of NxThera. The company developed the …See details»
NxThera Company Profile - Office Locations, Competitors ... - Craft
Jul 11, 2018 · NxThera is a company that develops water vapor energy technologies to treat endourology conditions. It offers a RezÅ«m system that applies the thermal energy stored in …See details»
Boston Scientific Announces Agreement To Acquire NxThera
Mar 21, 2018 · Boston Scientific (NYSE: BSX) today announced that it has entered into a definitive agreement to acquire NxThera, a privately-held company based in Maple Grove, …See details»
NxThera Acquired by Boston Scientific, Will Form New Cancer …
On March 21 st, Boston Scientific announced its intent to acquire Medical Alley-based NxThera, a medical device company developing the RezÅ«m system, a revolutionary, safe, and cost …See details»
Nxthera, Inc. Company Profile | Maple Grove, MN | Competitors ...
Find company research, competitor information, contact details & financial data for Nxthera, Inc. of Maple Grove, MN. Get the latest business insights from Dun & Bradstreet.See details»
Boston Scientific Announces Agreement To Acquire NxThera - PR …
Mar 21, 2018 · Boston Scientific has an existing minority investment in NxThera, which is expected to result in a net upfront payment of approximately $240 million upon closing and …See details»
NxThera - Products, Competitors, Financials, Employees, …
NxThera developed its Convective Water Vapor Energy (WAVE) technology platform to treat a variety of endourological conditions beginning with BPH. Use the CB Insights Platform to …See details»
Boston Scientific completes $406m NxThera acquisition
Boston Scientific has completed the acquisition of US-based firm NxThera and associated RezÅ«m system to treat benign prostatic hyperplasia (BPH) for a total of $406m.See details»
NxThera - Funding, Financials, Valuation & Investors - Crunchbase
NxThera develops medical technologies to treat a variety of endourology conditions, including BPH.See details»
Boston Scientific to acquire NxThera for $406m
Mar 22, 2018 · Boston Scientific has signed a definitive agreement to purchase US-based NxThera for an upfront payment of $306m, and up to another $100m in potential commercial …See details»
Boston Scientific Acquires Arboretum Ventures' Portfolio …
Apr 3, 2018 · Arboretum Ventures’s portfolio company, NxThera, was acquired by Boston Scientific in a $400 million deal for its treatment of benign prostatic hyperplasia (BPH).See details»
NXThera, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore NXThera, Inc. with its drug pipeline, therapeutic area, technology platform, 3 news.See details»
NxThera - Contacts, Employees, Board Members, Advisors & Alumni
NxThera has 6 current employee profiles, including Co-Founder, Chief Technology Officer & Board of Directors Michael Hoey. NxThera has 2 board members and advisors, including Sami …See details»
NxThera Reaches Milestone of 10,000 Patients Effectively Treated …
May 9, 2017 · NxThera's FDA-cleared RezÅ«m System is a next-generation transurethral needle ablation system using radiofrequency to create thermal energy that is convectively delivered to …See details»
NxThera CEO and Key Executive Team | Craft.co
NxThera's President & CEO is Bob Paulson. Other executives include Carmen Bringgold, CFO; Michael Hoey, CTO and 2 others. See the full leadership team at Craft.See details»
NxThera Announces Presentation of Two-Year Outcomes Data for …
May 15, 2017 · NxThera pioneered its convective radiofrequency thermotherapy platform technology to treat a variety of endourological conditions, beginning with BPH. The company is …See details»
NxThera Announces Three-Year Outcomes Data Demonstrating …
Jan 3, 2018 · NxThera pioneered its Convective Water Vapor Energy (WAVE ®) platform technology to treat a variety of endourological conditions, beginning with BPH.See details»
NxThera Announces Positive Results of Post-Market Study of Its ...
Aug 29, 2017 · NxThera's FDA-cleared RezÅ«m System is a next-generation transurethral needle ablation system indicated to treat symptoms of BPH using radiofrequency energy that is …See details»